A new report has claimed pharmaceutical companies are abandoning research into new drugs to deal with mental health issues.
Professor David Nutt, of Imperial College, explains how important investment into brain disorders are.
Get in touch with Today via
email
,
Twitter
or
Facebook
or text us on 84844.
Bookmark with:
What are these?
E-mail this to a friend